Supplementation before endoscopic therapy for esophageal varices reduces mental stress in patients with liver cirrhosis

Hepato-Gastroenterology

Volumn 58, Issue 107-108, 2011, Pages 814-818

  Itou, Minoru ^a   Kawaguchi, Takumi ^a   Taniguchi, Eitaro ^a   Oriishi, Tetsuharu ^a   Suetsugu, Takuro ^b   Hano, Risa ^b   Yoshihara, Miku ^b   Takishita, Midori ^b   Eguchi, Mayumi ^b   Ogiwara, Yukari ^b   Otsuyama, Juri ^b   Mutou, Michiko ^b   Ibi, Ryoko ^b   Akiyama, Ryoko ^b   Ono, Midori ^b   Otsuka, Momoka ^b   Nagamatsu, Ayu ^b   Tanaka, Suiko ^b   Miyakoda, Kenji ^a   Emori, Keigo ^a   Morita, Yukihiko ^a   Kumamoto, Masafumi ^a   Tsuruta, Osamu ^a   Sata, Michio ^a   more..

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cirrhosis; Endoscopic therapy; Esophageal varices; Supplementation

Indexed keywords

ADULT; AGED; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; ENDOSCOPIC INJECTION SCLEROTHERAPY; ENDOSCOPIC THERAPY; ESOPHAGEAL VARICES LIGATION; ESOPHAGUS VARICES; FEMALE; HUMAN; LIGATION; LIVER CIRRHOSIS; MALE; MENTAL STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SCLEROTHERAPY; STOMACH VARICES;

AGED; AMINO ACIDS, BRANCHED-CHAIN; ENDOSCOPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NUTRITIONAL SUPPORT; SCLEROTHERAPY; STRESS, PSYCHOLOGICAL;

EID: 80051634425     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Korenaga K, Korenaga M, Uchida K, Yamasaki T and Sakaida I: Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis. Hepatol Res 2008; 38:1087-1097.
2. Alberino F, Gatta A, Amodio P, et al: Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17:445-450. (Pubitemid 32505665)
3. Owen OE, Trapp VE, Reichard GA Jr., et al: Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72:1821-1832. (Pubitemid 14229062)
4. Plauth M, Cabre E, Riggio O, et al: ESPEN Guidelines on Enteral Nutrition: Liver disease. Clin Nutr 2006; 25:285-294. (Pubitemid 43811683)
5. Plauth M, Cabre E, Campillo B, et al: ESPEN Guidelines on Parenteral Nutrition: hepatology. Clin Nutr 2009; 28:436-444.
6. Gores GJ, Wiesner RH, Dickson ER, Zinsmeister AR, Jorgensen RA and Langworthy A: Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. Gastroenterology 1989; 96:1552-1559. (Pubitemid 19138700)
7. Tong MJ, el-Farra NS, Reikes AR and Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332:1463-1466.
8. Lai CL and Yuen MF: The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med 2007; 147:58-61.
9. Kawaguchi T, Taniguchi E, Itou M, et al: Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis. Hepatol Res 2008; 38:1178-1185.
10. Iwao T, Toyonaga A, Sato M, et al: Effect of posture-induced blood volume expansion on systemic and regional hemodynamics in patients with cirrhosis. J Hepatol 1997; 27:484-491. (Pubitemid 27390895)
11. Toyonaga A and Iwao T: Portal-hypertensive gastropathy. J Gastroenterol Hepatol 1998; 13:865-877.
12. Maqbool SB, Zhong H, Oraby HF and Sticklen MB: Transformation of oats and its application to improving osmotic stress tolerance. Methods Mol Biol 2009; 478:149-v 168.
13. Verne GN, Soldevia-Pico C, Robinson ME, Spicer KM and Reuben A: Autonomic dysfunction and gastroparesis in cirrhosis. J Clin Gastroenterol 2004; 38:72-76.
14. Shimoyama Y, Kusano M, Kawamura O, et al: High-viscosity liquid meal accelerates gastric emptying. Neurogastroenterol Motil 2007; 19:879-886. (Pubitemid 350060609)
15. Muto Y, Sato S, Watanabe A, et al: Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006; 35:204-214.
16. Bonelli RM, Wenning GK and Kapfhammer HP: Huntington's disease: present treatments and future therapeutic modalities. Int Clin Psychopharmacol 2004; 19:51-62. (Pubitemid 38316763)
17. Rampello L, Chiechio S, Raffaele R, Vecchio I and Nicoletti F: The SSRI, Citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa. Clin Neuropharmacol 2002; 25:21-24. (Pubitemid 34178244)
18. Wilson JF, Laine C and Goldmann D: In the clinic. Peripheral arterial disease. Ann Intern Med 2007; 146:1-16.
19. Hirasawa A, Tsumaya K, Awaji T, et al: Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005; 11:90-94. (Pubitemid 40215843)
20. Perry T and Greig NH: Enhancing central nervous system endogenous GLP-1 receptor pathways for intervention in Alzheimer's disease. Curr Alzheimer Res 2005; 2:377-385. (Pubitemid 40980196)